A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT)
<h4>Background and aims</h4> We hypothesized that a drug’s clinical signature (or phenotype) of liver injury can be assessed and used to quantitatively develop a computer-assisted DILI causality assessment-tool (DILI-CAT). Therefore, we evaluated drug-specific DILI-phenotypes for amoxici...
Main Authors: | Hans L. Tillmann, Ayako Suzuki, Michael Merz, Richard Hermann, Don C. Rockey |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521919/?tool=EBI |
Similar Items
-
A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT).
by: Hans L Tillmann, et al.
Published: (2022-01-01) -
Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM)
by: Rolf Teschke, et al.
Published: (2021-03-01) -
Drug-induced liver injury (DILI) - mechanisms and diagnostic
by: Marta Małysz, et al.
Published: (2022-10-01) -
The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment
by: Marta Moreno-Torres, et al.
Published: (2022-06-01) -
Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
by: Camilla eStephens, et al.
Published: (2012-11-01)